BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17670718)

  • 1. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?
    Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):661-4. PubMed ID: 17670718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival?
    Modi A; Vohra HA; Weeden DF
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):467-73. PubMed ID: 19155223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pyloroplasty following esophagectomy improve early clinical outcomes?
    Khan OA; Manners J; Rengarajan A; Dunning J
    Interact Cardiovasc Thorac Surg; 2007 Apr; 6(2):247-50. PubMed ID: 17669829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy following complete resection of non-small-cell lung cancer is of small but significant benefit in terms of survival.
    West D; Kirk AJ; Dunning J
    Interact Cardiovasc Thorac Surg; 2006 Aug; 5(4):488-92. PubMed ID: 17670625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic benefit of surgery following chemoradiotherapy for squamous cell carcinoma of the oesophagus.
    McGlone ER; Khan OA
    Int J Surg; 2012; 10(7):341-4. PubMed ID: 22641124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant therapy in oesophageal cancer surgery].
    Imdahl A
    Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
    Msika S; Hay JM
    J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
    Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the best neoadjuvant regimen prior to oesophagectomy: chemotherapy or chemoradiotherapy?
    Hamilton E; Vohra RS; Griffiths EA
    Int J Surg; 2014; 12(3):196-9. PubMed ID: 24361472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
    Mooney MM
    J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthoracic versus transhiatal esophagectomy for distal esophageal cancer: which is superior?
    Colvin H; Dunning J; Khan OA
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):265-9. PubMed ID: 21051381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 19. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy.
    Brown WA; Thomas J; Gotley D; Burmeister BH; Lim KH; Martin I; Walpole ET; Thomson DB; Harvey JA; Smithers BM
    Br J Surg; 2004 Feb; 91(2):199-204. PubMed ID: 14760668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.